The Nasdaq Biotechnology Index fell by 2%. Among the constituent stocks, Jyong Biotech dropped by 20.95%, BridgeBio Pharma fell by 15.21%, Sionna Therapeutics decreased by 15.12%, Abcellera Biologics declined by 14.98%, and Editas Medicine fell by 14.62%. Gilead Sciences rose by 2.15%, Silence Therapeutics increased by 5.12%, Erasca went up by 5.69%, and Phibro Animal Health surged by 22.02%Wallstreetcn·Feb 5, 2026 at 11:56 PMXLV+1.32%ARKG-3.97%
The Nasdaq Biotechnology Index fell by approximately 1.7%. Among the constituent stocks, Regenxbio dropped 17.90%, Altimmune fell 17.15%, Jyong Biotech decreased by 15.95%, Coherus BioSciences declined 11.75%, Relay Therapeutics Inc fell 10.06%, and Maravai Lifesciences dropped 10.00%. Meanwhile, Apellis Pharma rose 5.82%, Kodiak Sciences increased by 6.28%, Alumis went up 6.58%, and Zenas Biopharma gained 7.03%Wallstreetcn·Jan 28, 2026 at 11:57 PMRGNX0.00%BBH-0.82%
